the current study advertised on clinical trial (n = 40) of first time or VIV replacement will add to that information.........data hopefully available in the next 18 months.......
I agree about the dilution impact - the upside of the anticipated potential pie in the sky dream SP is still there and could (should) exceed the dilution effect....it just may take longer than many of us hope for......
- Forums
- ASX - By Stock
- I'm done.!!!!
the current study advertised on clinical trial (n = 40) of first...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.20 |
Change
0.010(0.08%) |
Mkt cap ! $257.6M |
Open | High | Low | Value | Volume |
$12.00 | $12.20 | $11.75 | $213.8K | 17.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | $12.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.20 | 1970 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1125 | 11.890 |
1 | 500 | 11.880 |
4 | 379 | 11.820 |
2 | 272 | 11.810 |
2 | 1109 | 11.800 |
Price($) | Vol. | No. |
---|---|---|
12.200 | 1971 | 2 |
12.850 | 99 | 1 |
13.300 | 200 | 1 |
14.440 | 25 | 1 |
14.500 | 60 | 1 |
Last trade - 12.24pm 02/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online